ON the basis of current evidence, the administration of booster doses of vaccines to fully vaccinated individuals in the general population is not urgent “, reiterates the EMA, the European Medicines Agency, publishing the technical report published yesterday by the European Center for disease prevention and control (ECDC). “The report also notes that additional doses should already be considered for people with severely weakened immune systems as part of their primary vaccination,” highlights the EMA.
Covid vaccine, the Viola immunologist: “The third dose only for certain categories of patients”
by Giuliano Aluffi
The European Medicines Agency reiterates that “the priority now should be to vaccinate all eligible individuals who have not yet completed the recommended vaccination course”. “It is important to distinguish between booster doses for people with normal immune systems and additional doses for those with weakened immune systems. Some studies report that an additional dose of the vaccine can improve the immune response in immunosuppressed individuals, such as recipients of organ transplantation whose initial responses to vaccination were low. In such cases, the option of administering an additional dose should be considered already now. The possibility of providing an additional dose, as a precautionary measure, could also be considered. to frail elderly people, in particular those who live in closed environments such as residents of long-term care facilities “, reads the ECDC recommendations taken up by the EMA.
Alberto Mantovani: “To beat Covid we need new vaccines”
by Alberto Mantovani
The EMA recalled that the evidence on the efficacy of the vaccine and on the duration of protection show that all vaccines authorized in the European Union / European Economic Area (EEA) are currently “highly protective against hospitalization, serious illness and deaths linked to Covid-19, while about one in three adults in the EU / See over the age of 18 is not yet fully vaccinated “. The EMA recalled that in order to complete vaccination efforts, it is also crucial to continue to apply measures such as physical distance, hand and respiratory hygiene and the use of face masks where necessary, particularly in high-pressure environments. high risk such as long-term care facilities or hospital wards with patients at risk of severe Covid-19. (Beb)
In the meantime, Moderna plans to present data relating to the third dose of the anti Covid-19 vaccine to the United States drug regulatory body, the Food and Drug Administration (Fda), to the European one (Ema) and to those of other countries in the coming days. of all the world.
Covid, the US decides: third dose of the fragile vaccine
by Giuliano Aluffi
.